Penile Lengthening Pre-Penile Prosthesis Implantation
Prospective, Randomized, Controlled Trial to Evaluate the Effect of Preoperative Penile Traction Therapy on Post-penile Implant Length and Patient Satisfaction
1 other identifier
interventional
48
1 country
1
Brief Summary
The goal of this study is to determine whether or not the use of a penile traction therapy device known as RestoreX prior to implantation of a penile prosthesis can increase the length of the implant used during surgery. The device used in this study is commercially available and has been used successfully to facilitate penile lengthening in patients with diabetes and after a certain type of prostate surgery. Use of the device has not been shown to have any detrimental effects on sexual or overall health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2025
CompletedFirst Posted
Study publicly available on registry
July 8, 2025
CompletedStudy Start
First participant enrolled
August 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
September 5, 2025
August 1, 2025
11 months
June 27, 2025
August 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Penile Length
Change in stretched penile length measured at time of enrollment and intraoperatively at the time of IPP implantation, measured in cm.
At screening to approximately three months after enrollment at the time of penile prosthesis implantation
Prosthesis size
Size of inflatable penile prosthesis cylinders placed
0-4 months after enrollment at the time of penile prosthesis implantation
Sexual Satisfaction
Change in patient-reported satisfaction with their sexual function from enrollment to final postoperative follow up using the validated IIEF-15 (International Index of Erectile function - 15 item) questionnaire, which has a minimum score of 6 and maximum score of 75 with a larger number indicating improved sexual satisfaction. The change seen in participants assigned to the RestoreX device arm will be compared to the change seen in patients assigned to the control arm.
At enrollment and at three-month postoperative follow up.
Incidence of Satisfaction with Penile Length
A comparison of the incidence of participants reporting satisfaction with their penile length, expressed as a percentage or all participants within each group, based on participant reporting to an investigator during their surgical follow up.
3-8 months postoperatively
Secondary Outcomes (4)
Compliance with Therapy
0-4 months after enrollment, intervention arm only
Incidence of adverse events
0-16 months
Patient Satisfaction with Prosthesis Use
3-7 months
Patient Satisfaction with Prosthesis Use
3-8 months
Study Arms (2)
Penile Prosthesis Implantation
ACTIVE COMPARATORPatients with erectile dysfunction presenting for placement of a three-piece inflatable prosthesis who are randomized to the no intervention arm will proceed directly to implantation of a standard-of-care inflatable penile prosthesis at the next available surgical appointment. They will not use the RestoreX penile traction device. They will complete standardized assessments of sexual function and satisfaction before and after placement.
RestoreX and Penile Prosthesis Implantation
EXPERIMENTALPatients with erectile dysfunction presenting for placement of a three-piece inflatable prosthesis who are randomized to the intervention arm will be provided with a RestoreX penile traction device, which they will utilize for three months prior to implantation of a standard-of-care inflatable penile prosthesis. They will complete standardized assessments of sexual function and satisfaction before and after placement, as well as a device use diary.
Interventions
Patients will be randomized into one of two groups: penile traction therapy 30 min 3x/day x 3 months, or control (no treatment). Preoperative erectile function surveys will be recorded in the EMR per standard of care. Following randomization, patients allocated to the treatment arm will be instructed how to use the device properly. Patients in the treatment arm will record a daily journal of use of the device (Appendix 1). After a minimum of 3 months, patients in the treatment arm will return for their scheduled procedure. Control arm patients will be scheduled directly for an OR date.
Implantation of a three-component inflatable penile prosthesis.
Eligibility Criteria
You may qualify if:
- Have a documented diagnosis of erectile dysfunction
- Can provide informed consent
- Are willing and able to comply with study procedures and visit schedules
- Are to be scheduled for a planned standard of care implantation of an inflatable penile prosthesis
You may not qualify if:
- Prior ischemic priapism
- Prior implantation of a penile prosthesis
- Prior use of any penile traction device
- Any prior penile surgeries other than circumcision
- Prior pelvic radiation
- Current or prior androgen deprivation therapy
- Active genital infection
- History of neophallus creation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Pathright Medicalcollaborator
Study Sites (1)
UPMC Mercy Hospital, Urology
Pittsburgh, Pennsylvania, 15219, United States
Related Publications (5)
Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, Trost L. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. J Urol. 2019 Sep;202(3):599-610. doi: 10.1097/JU.0000000000000245. Epub 2019 Aug 8.
PMID: 30916626BACKGROUNDZganjar A, Toussi A, Ziegelmann M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trial. BJU Int. 2023 Aug;132(2):217-226. doi: 10.1111/bju.16033. Epub 2023 May 9.
PMID: 37088866BACKGROUNDToussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial. J Urol. 2021 Aug;206(2):416-426. doi: 10.1097/JU.0000000000001792. Epub 2021 Jun 1.
PMID: 34060339BACKGROUNDTrost LW, Munarriz R, Wang R, Morey A, Levine L. External Mechanical Devices and Vascular Surgery for Erectile Dysfunction. J Sex Med. 2016 Nov;13(11):1579-1617. doi: 10.1016/j.jsxm.2016.09.008.
PMID: 27770853BACKGROUNDLevine LA, Rybak J. Traction therapy for men with shortened penis prior to penile prosthesis implantation: a pilot study. J Sex Med. 2011 Jul;8(7):2112-7. doi: 10.1111/j.1743-6109.2011.02285.x. Epub 2011 Apr 14.
PMID: 21492409BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
J. Peter Rubin, MD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Endowed Chair of Plastic Surgery
Study Record Dates
First Submitted
June 27, 2025
First Posted
July 8, 2025
Study Start
August 26, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
September 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
To protect the privacy of the patients involved in the study, we do not plan to share IDP.